Top Key Players Sun Pharmaceutical Industries Ltd Sanofi Pfizer.Inc Novo-Nordisk A/S Eli Lilly and Company Boehringer Ingelheim International GmbH AstraZeneca Amylyx Pharmaceuticals Recent Developments In July 2024, Amylyx Pharmaceuticals strategically acquired Avexitide, a promising GLP-1 receptor agonist, from Eiger Biopharmaceuticals
1.6 to 2.0 grams of protein per kilogram of body weight, per day
Thus, two head-to-head trials demonstrated that liraglutide was superior for weight loss
Since betaine and L-carnitine are both approved for use in complete and balanced diets, this study provides promising evidence for additional immune-supporting ingredients in pet food
Like any medication, GLP-1 receptor agonists come with potential side effects
Other ingredients Gelatin capsule, magnesium stearate (vegetable source)